A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples